IRIS
MARCHETTI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 802
EU - Europa 383
AS - Asia 107
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 802
IE - Irlanda 224
CN - Cina 61
UA - Ucraina 51
DE - Germania 43
TR - Turchia 29
SE - Svezia 23
BE - Belgio 17
VN - Vietnam 12
IT - Italia 9
FR - Francia 7
FI - Finlandia 4
GB - Regno Unito 4
IN - India 2
JP - Giappone 2
AR - Argentina 1
ES - Italia 1
EU - Europa 1
NZ - Nuova Zelanda 1
SG - Singapore 1
Totale 1.295
Salva come PNG Salva come JPEG
Città #
Dublin 224
Chandler 208
Jacksonville 173
Ann Arbor 53
New York 53
Lawrence 29
Princeton 29
Ashburn 28
Beijing 26
Izmir 23
Wilmington 20
Brussels 17
Bremen 12
Dong Ket 12
Dearborn 10
Boardman 9
San Mateo 8
Nanchang 7
Nanjing 6
Seattle 6
Woodbridge 4
Des Moines 3
Ningbo 3
Taizhou 3
Tianjin 3
Baotou 2
Helsinki 2
Houston 2
Jiaxing 2
Lanzhou 2
Norwalk 2
Pune 2
San Francisco 2
Shanghai 2
Tokyo 2
Bellante 1
Buenos Aires 1
Changsha 1
Chieti 1
Edinburgh 1
Frankfurt am Main 1
Grosseto 1
Hebei 1
Istanbul 1
Kunming 1
L'aquila 1
Los Angeles 1
Marseille 1
Nuremberg 1
Shenyang 1
Stockholm 1
Verona 1
Wellington 1
Totale 1.007
Salva come PNG Salva come JPEG
Nome #
Recidive loco-regionali da carcinoma colo-rettale: risultati a breve termine della perfusione pelvica ipossica. 61
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 61
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 60
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 59
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 59
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 55
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 53
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 53
Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study 52
Factors influencing the clinical presentation of breakthrough pain in cancer patients 52
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 46
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 45
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 45
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 45
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 44
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 43
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 42
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 42
Evaluation of prognostic factors for survival in transverse colon cancer 42
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 41
What cancer patients actually know regarding Medical Cannabis? A cross-sectional survey with a critical analysis of the current attitudes 41
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 39
Integration between oncology and palliative care: Does one size fit all? 38
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program 37
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 35
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 34
Is it possible to teach pain therapy playing basketball? 33
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories 32
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results 28
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 24
Totale 1.341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 2 1 30
2019/2020175 10 0 9 0 0 10 61 5 35 16 2 27
2020/2021227 4 31 2 28 29 4 29 8 35 4 40 13
2021/2022110 3 3 7 5 11 0 2 11 10 3 16 39
2022/2023612 37 51 3 80 34 64 0 32 280 4 20 7
2023/2024141 13 12 4 12 15 78 0 7 0 0 0 0
Totale 1.341